ResMed | RMD - Cash And Equivalent



ResMed reported $1.21B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Ansell USD 912.3M 747.2M Jun/2024
Avita Medical AUD 14.05M 3.4M Dec/2024
Cochlear AUD 383.1M 130.5M Dec/2024
CSL 1.52B 133M Dec/2024
Fisher & Paykel Healthcare NZD 264.5M 147.9M Mar/2025
Healius 60.1M 25.6M Jun/2024
Integral Diagnostics 17.99M 15.86M Dec/2023
Mayne Pharma 110.07M 838K Jun/2024
Nanosonics AUD 4.84M 124.71M Dec/2024
Polynovo 45.91M 330K Jun/2024
Ramsay Health Care AUD 341.1M 321.2M Dec/2024
Regis Healthcare AUD 64.9M 21.69M Jun/2024
ResMed USD 1.21B 687.51M Jun/2025
Sigma Healthcare 16.65M 3.68M Jan/2023
Sonic Healthcare 645M 25.39M Jun/2024
Telix Pharmaceuticals 710.35M 587.11M Dec/2024